Biogen (BIIB) FCF Margin (2009 - 2026)
Biogen (BIIB) posted quarterly FCF Margin of 14.91% for Q2 2026, up 984.0% year-over-year from 1.38% in Q2 2025, and down 37.83% quarter-over-quarter from 23.98% in Q1 2026.
Biogen (BIIB) FCF Margin (2009 - 2026) Analysis & Trends
Biogen's FCF Margin history runs 18 years deep, the most recent figure standing at 14.91% for Q2 2026.
- In Q2 2026, FCF Margin rose 984.0% year-over-year to 14.91%; the TTM figure through Jun 2026 stood at 26.89% (up 710.0% YoY), while the FY2025 annual figure was 20.73%, down 739.0% from the prior year.
- FCF Margin for Q2 2026 stood at 14.91%, down from 23.98% in the prior quarter.
- The five-year high for FCF Margin was 48.38% in Q3 2025, with the low at 10.28% in Q4 2022.
- The 5-year median for FCF Margin is 20.51% (2023), against an average of 18.33%.
- The sharpest annual moves came in 2022 and 2024: FCF Margin tumbled 3905 bps in 2022, then surged 3161 bps in 2024.
- Biogen's FCF Margin stood at 10.28% in 2022, then soared by 79 bps to 2.21% in 2023, then surged by 1431 bps to 29.4% in 2024, then tumbled by 30 bps to 20.53% in 2025, then fell by 27 bps to 14.91% in 2026.
- Business Quant data shows BIIB's FCF Margin at 14.91% in Q2 2026, 23.98% in Q1 2026, and 20.53% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 38.60% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -12.07% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.01% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 3.90% |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 14.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.91% |
| Mar 31, 2026 | 23.98% |
| Dec 31, 2025 | 20.53% |
| Sep 30, 2025 | 48.38% |
| Jun 30, 2025 | 5.08% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | 29.40% |
| Sep 30, 2024 | 36.52% |
| Jun 30, 2024 | 24.03% |
| Mar 31, 2024 | 22.15% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | 20.48% |
| Jun 30, 2023 | 16.94% |
| Mar 31, 2023 | 15.78% |
| Dec 31, 2022 | -10.28% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 27.02% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | 28.78% |
| Sep 30, 2021 | 27.47% |